ALNY

Alnylam Pharmaceuticals Inc

$293.53

2.15 (0.74%) Today

0.01 (0.00%) After-hours

— up— down

Compare ALNY

Market Cap

$38.90B-9.1%

Revenue (TTM)

$4.14B+82.6%

Net Income (TTM)

$557.88M

EPS (TTM)

4.18

Shares Out

133.51M

P/E Ratio

67.39

Forward P/E

31.70

Open

$296.97

Previous Close

$291.37

Day Range

$291.90 – $298.06

52-Week Range

$273.11 – $495.55

Beta

0.27

Volume

1.34M

Avg Volume

1.13M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About ALNY

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.